Afimoxifene
Afimoxifene (pronounced as a-fi-mox-i-fen) is a Selective Estrogen Receptor Modulator (SERM) that is used in the treatment of Breast Cancer. It is a derivative of Tamoxifen, and is also known by its brand name, 4-Hydroxytamoxifen.
Etymology
The term "Afimoxifene" is derived from its chemical structure. The prefix "Afi-" is derived from the chemical name 4-Hydroxytamoxifen, and "-moxifene" is a common suffix used in the names of SERMs.
Pharmacology
Afimoxifene binds to Estrogen Receptors in the body, blocking the effects of estrogen. This can help to slow the growth of certain types of breast cancer cells that require estrogen to grow.
Usage
Afimoxifene is used in the treatment of hormone receptor-positive breast cancer. It is typically used in postmenopausal women, but can also be used in premenopausal women in combination with other treatments.
Side Effects
Common side effects of Afimoxifene include hot flashes, nausea, and fatigue. More serious side effects can include blood clots, stroke, and endometrial cancer.
Related Terms
External links
- Medical encyclopedia article on Afimoxifene
- Wikipedia's article - Afimoxifene
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski